title: Current and future immunomodulation strategies to restore tolerance in autoimmune diseases.
abstract: Autoimmune diseases reflect a breakdown in self-tolerance that results from defects in thymic deletion of potentially autoreactive T cells (central tolerance) and in T-cell intrinsic and extrinsic mechanisms that normally control potentially autoreactive T cells in the periphery (peripheral tolerance). The mechanisms leading to autoimmune diseases are multifactorial and depend on a complex combination of genetic, epigenetic, molecular, and cellular elements that result in pathogenic inflammatory responses in peripheral tissues driven by self-antigen-specific T cells. In this article, we describe the different checkpoints of tolerance that are defective in autoimmune diseases as well as specific events in the autoimmune response which represent therapeutic opportunities to restore long-term tolerance in autoimmune diseases. We present evidence for the role of different pathways in animal models and the therapeutic strategies targeting these pathways in clinical trials in autoimmune diseases.
authors.affiliation: UCSF Diabetes Center, University of California at San Francisco, 94143, USA. Jeff.Bluestone@ucsf.edu
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Bluestone
authors.forename: Hélène
authors.initials: H
authors.lastname: Bour-Jordan
mesh_terms: D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology* / Q000503:physiopathology* / Q000628:therapy; D006801:Humans; D007108:Immune Tolerance; D007167:Immunotherapy / Q000379:methods*; D061166:Peripheral Tolerance / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*